Filing Flows

Filing Flows › Generate Biomedicines (GENB) › Who owns the stock

Who owns Generate Biomedicines (GENB) stock

86 funds reported Generate Biomedicines (GENB) shares in their latest 13F filings, worth $544M in all. The largest holder is FMR LLC ($88.1M). Last quarter 53 funds added to their stakes and 27 cut them.

Largest holders of GENB (13F)Largest holders of GENB (13F)FMR LLC$88.1MCapital World Investors$71.1MPrice T Rowe Associates$36.4MArch Venture Management, LLC$32.8MHarbourvest Partners LLC$29.1MBlackRock$28.0MBanque Pictet & CIE SA$26.6MBaker Bros. Advisors LP$24.0MDeep Track Capital, LP$22.5MARK Investment Management LLC$21.7M

Largest holders (13F)

FundSharesValueChangeQuarter
FMR LLC5,221,599$88.1Mincrease2026-06-30
Capital World Investors4,215,632$71.1Mincrease2026-06-30
Price T Rowe Associates2,156,627$36.4Mincrease2026-06-30
Arch Venture Management, LLC1,944,426$32.8Munchanged2026-06-30
Harbourvest Partners LLC1,722,210$29.1Munchanged2026-06-30
BlackRock1,659,966$28.0Mnew2026-06-30
Banque Pictet & CIE SA1,773,043$26.6Mnew2026-09-30
Baker Bros. Advisors LP1,423,602$24.0Munchanged2026-06-30
Deep Track Capital, LP1,333,815$22.5Mnew2026-06-30
ARK Investment Management LLC1,284,617$21.7Mincrease2026-06-30
Vanguard Capital Management LLC1,132,750$19.1Mincrease2026-06-30
Harvard Management1,111,100$18.7Munchanged2026-06-30
NVIDIA833,325$14.1Munchanged2026-06-30
Davern Capital Partners, LP824,679$13.9Mincrease2026-06-30
Siren, L.L.C.736,104$12.4Munchanged2026-06-30

Generate Biomedicines' latest quarter

Generate Biomedicines, Q2 2026: revenue $6.3M (-38% year over year), net loss $67.3M, operating cash flow −$57.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most GENB stock?

By the latest 13F filings: FMR LLC ($88.1M); Capital World Investors ($71.1M); Price T Rowe Associates ($36.4M); Arch Venture Management, LLC ($32.8M); Harbourvest Partners LLC ($29.1M).

What is the short interest in GENB?

8,930,609 shares were sold short at the 2026-10-15 settlement, 20.41% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.